Sona Nanotech Inc. Share Price
Equities
SONA
CA83541C1059
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.35 CAD | 0.00% | -16.67% | +45.83% |
04-12 | Sona Nanotech Provides Interim Results of Dalhousie Study | MT |
04-12 | Sona Nanotech Provides Interim Results of Dalhousie Efficacy Study | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 16.64M 22.87M 1.33B |
---|---|---|---|---|---|
Net income 2022 | -2M -2.75M -160M | Net income 2023 | -2M -2.75M -160M | EV / Sales 2022 | - |
Net Debt 2022 | 444K 610K 35.47M | Net Debt 2023 | 412K 567K 32.93M | EV / Sales 2023 | - |
P/E ratio 2022 |
-4.2
x | P/E ratio 2023 |
-6
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 84.54% |
1 week | -16.67% | ||
Current month | -22.22% | ||
1 month | -22.22% | ||
3 months | +25.00% | ||
6 months | +100.00% | ||
Current year | +45.83% |
Managers | Title | Age | Since |
---|---|---|---|
Michael McAlduff
FOU | Founder | - | 16/11/04 |
Kulbir Singh
FOU | Founder | - | 16/11/04 |
David Regan
CEO | Chief Executive Officer | 55 | 06/07/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
J. Lievonen
CHM | Chairman | - | 02/11/20 |
Neil Fraser
BRD | Director/Board Member | - | 03/01/22 |
Director/Board Member | 59 | 18/12/19 |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 0.35 | -14.63% | 120,130 |
26/04/24 | 0.41 | -2.38% | 2,214 |
25/04/24 | 0.42 | +5.00% | 22,525 |
24/04/24 | 0.4 | -4.76% | 28,225 |
23/04/24 | 0.42 | 0.00% | 11,000 |
Delayed Quote Canadian Securities Exchange, April 29, 2024 at 08:54 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+45.83% | 25.42M | |
-3.14% | 186B | |
-2.42% | 107B | |
-4.24% | 67.44B | |
+2.89% | 50.03B | |
+16.43% | 47.81B | |
+4.79% | 41.03B | |
+2.68% | 26.85B | |
+3.53% | 25.82B | |
-0.80% | 25.01B |
- Stock Market
- Equities
- SONA Stock